Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

296 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Publication Date timeline is not available.
Page 1
Endothelium-associated biomarkers mid-regional proadrenomedullin and C-terminal proendothelin-1 have good ability to predict 28-day mortality in critically ill patients with SARS-CoV-2 pneumonia: A prospective cohort study.
van Oers JAH, Kluiters Y, Bons JAP, de Jongh M, Pouwels S, Ramnarain D, de Lange DW, de Grooth HJ, Girbes ARJ. van Oers JAH, et al. Among authors: de jongh m, de lange dw, de grooth hj. J Crit Care. 2021 Dec;66:173-180. doi: 10.1016/j.jcrc.2021.07.017. Epub 2021 Jul 20. J Crit Care. 2021. PMID: 34340901 Free PMC article.
Stop Antibiotics on guidance of Procalcitonin Study (SAPS): a randomised prospective multicenter investigator-initiated trial to analyse whether daily measurements of procalcitonin versus a standard-of-care approach can safely shorten antibiotic duration in intensive care unit patients--calculated sample size: 1816 patients.
Assink-de Jong E, de Lange DW, van Oers JA, Nijsten MW, Twisk JW, Beishuizen A. Assink-de Jong E, et al. Among authors: de lange dw. BMC Infect Dis. 2013 Apr 16;13:178. doi: 10.1186/1471-2334-13-178. BMC Infect Dis. 2013. PMID: 23590389 Free PMC article. Clinical Trial.
Mortality after hospital discharge in ICU patients.
Brinkman S, de Jonge E, Abu-Hanna A, Arbous MS, de Lange DW, de Keizer NF. Brinkman S, et al. Among authors: de lange dw, de keizer nf, de jonge e. Crit Care Med. 2013 May;41(5):1229-36. doi: 10.1097/CCM.0b013e31827ca4e1. Crit Care Med. 2013. PMID: 23591209
Efficacy and safety of procalcitonin guidance in reducing the duration of antibiotic treatment in critically ill patients: a randomised, controlled, open-label trial.
de Jong E, van Oers JA, Beishuizen A, Vos P, Vermeijden WJ, Haas LE, Loef BG, Dormans T, van Melsen GC, Kluiters YC, Kemperman H, van den Elsen MJ, Schouten JA, Streefkerk JO, Krabbe HG, Kieft H, Kluge GH, van Dam VC, van Pelt J, Bormans L, Otten MB, Reidinga AC, Endeman H, Twisk JW, van de Garde EMW, de Smet AMGA, Kesecioglu J, Girbes AR, Nijsten MW, de Lange DW. de Jong E, et al. Among authors: de lange dw, de smet amga. Lancet Infect Dis. 2016 Jul;16(7):819-827. doi: 10.1016/S1473-3099(16)00053-0. Epub 2016 Mar 2. Lancet Infect Dis. 2016. PMID: 26947523 Clinical Trial.
296 results